| MeSH term | MeSH ID | Detail |
|---|---|---|
| Adenocarcinoma | D000230 | 166 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Diabetic Nephropathies | D003928 | 39 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Hypothyroidism | D007037 | 32 associated lipids |
| Glioma | D005910 | 112 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Hypercholesterolemia | D006937 | 91 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
Mevalonic acid
Mevalonic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 10134 references associated with Mevalonic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Mevalonic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Mevalonic acid
PubChem Biomolecular Interactions and Pathways
NCBI Entrez Crosslinks
All references with Mevalonic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Wani TA et al. | The effects of rosuvastatin on the serum cortisol, serum lipid, and serum mevalonic acid levels in the healthy Indian male population. | 2010 | AAPS PharmSciTech | pmid:20300897 |
| Morrone D et al. | Increasing diterpene yield with a modular metabolic engineering system in E. coli: comparison of MEV and MEP isoprenoid precursor pathway engineering. | 2010 | Appl. Microbiol. Biotechnol. | pmid:19777230 |
| Wang C et al. | Farnesol production from Escherichia coli by harnessing the exogenous mevalonate pathway. | 2010 | Biotechnol. Bioeng. | pmid:20552672 |
| Fukunaga M et al. | Mast cell death induced by 24(S),25-epoxycholesterol. | 2010 | Exp. Cell Res. | pmid:20854813 |
| Honour JW | Steroid assays in paediatric endocrinology. | 2010 | J Clin Res Pediatr Endocrinol | pmid:21274330 |
| Head BP et al. | Loss of caveolin-1 accelerates neurodegeneration and aging. | 2010 | PLoS ONE | pmid:21203469 |
| Hamdy RC | Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass. | 2010 | Drug Des Devel Ther | pmid:21151620 |
| Targett-Adams P et al. | Lipid metabolism and HCV infection. | 2010 | Viruses | pmid:21994676 |
| Snoeren TA et al. | The herbivore-induced plant volatile methyl salicylate negatively affects attraction of the parasitoid Diadegma semiclausum. | 2010 | J. Chem. Ecol. | pmid:20407809 |
| Lefurgy ST et al. | Probing ligand-binding pockets of the mevalonate pathway enzymes from Streptococcus pneumoniae. | 2010 | J. Biol. Chem. | pmid:20404339 |
| Palozza P et al. | Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines. | 2010 | Carcinogenesis | pmid:20699249 |
| Clendening JW et al. | Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma. | 2010 | Blood | pmid:20360469 |
| Delang L et al. | Antiviral therapy for hepatitis C virus: beyond the standard of care. | 2010 | Viruses | pmid:21994657 |
| Klawitter J et al. | Effects of lovastatin on breast cancer cells: a proteo-metabonomic study. | 2010 | Breast Cancer Res. | pmid:20205716 |
| Catros V et al. | [Tgammadelta lymphocytes in oncology: unconventional killer lymphocytes]. | 2010 | Med Sci (Paris) | pmid:20188051 |
| Pontillo A et al. | The inhibition of mevalonate pathway induces upregulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency. | 2010 | Eur. J. Hum. Genet. | pmid:20179743 |
| Yang Z et al. | Synergistic actions of atorvastatin with gamma-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells. | 2010 | Int. J. Cancer | pmid:19626588 |
| Acquavella N et al. | Effect of simvastatin on endothelial cell apoptosis mediated by Fas and TNF-alpha. | 2010 | Cytokine | pmid:19932975 |
| Coscia M et al. | Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. | 2010 | J. Cell. Mol. Med. | pmid:19818098 |
| Massaro M et al. | Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability. | 2010 | Cardiovasc. Res. | pmid:19946014 |
| Kones R | Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective. | 2010 | Drug Des Devel Ther | pmid:21267417 |
| Hooff GP et al. | Isoprenoids, small GTPases and Alzheimer's disease. | 2010 | Biochim. Biophys. Acta | pmid:20382260 |
| Räikkönen J et al. | Mevalonate pathway intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells. | 2010 | Biochem. Pharmacol. | pmid:19819230 |
| Rossi J et al. | Laminar shear stress prevents simvastatin-induced adhesion molecule expression in cytokine activated endothelial cells. | 2010 | Eur. J. Pharmacol. | pmid:20863785 |
| Kaneda T et al. | Statins inhibited erythropoietin-induced proliferation of rat vascular smooth muscle cells. | 2010 | Eur. J. Pharmacol. | pmid:20851116 |
| Barter MJ et al. | Lipophilic statins prevent matrix metalloproteinase-mediated cartilage collagen breakdown by inhibiting protein geranylgeranylation. | 2010 | Ann. Rheum. Dis. | pmid:20693272 |
| Tsuchiya M et al. | Cholesterol biosynthesis pathway intermediates and inhibitors regulate glucose-stimulated insulin secretion and secretory granule formation in pancreatic beta-cells. | 2010 | Endocrinology | pmid:20685866 |
| Kocsis GF et al. | Expression of genes related to oxidative/nitrosative stress in mouse hearts: effect of preconditioning and cholesterol diet. | 2010 | Med. Sci. Monit. | pmid:20037483 |
| Tekpli X et al. | Membrane remodeling, an early event in benzo[a]pyrene-induced apoptosis. | 2010 | Toxicol. Appl. Pharmacol. | pmid:19931295 |
| Clendening JW et al. | Dysregulation of the mevalonate pathway promotes transformation. | 2010 | Proc. Natl. Acad. Sci. U.S.A. | pmid:20696928 |
| Rico J et al. | Enhanced production of a plant monoterpene by overexpression of the 3-hydroxy-3-methylglutaryl coenzyme A reductase catalytic domain in Saccharomyces cerevisiae. | 2010 | Appl. Environ. Microbiol. | pmid:20675444 |
| Okamura E et al. | Unprecedented acetoacetyl-coenzyme A synthesizing enzyme of the thiolase superfamily involved in the mevalonate pathway. | 2010 | Proc. Natl. Acad. Sci. U.S.A. | pmid:20534558 |
| Chen CC et al. | Effect of pravastatin on ventricular arrhythmias in infarcted rats: role of connexin43. | 2010 | J. Appl. Physiol. | pmid:20466804 |
| Norman KL and Sarnow P | Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms. | 2010 | J. Virol. | pmid:19846523 |
| Kato S et al. | Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase. | 2010 | J. Cell. Mol. Med. | pmid:19432822 |
| Jiang XS et al. | Quantitative proteomics analysis of inborn errors of cholesterol synthesis: identification of altered metabolic pathways in DHCR7 and SC5D deficiency. | 2010 | Mol. Cell Proteomics | pmid:20305089 |
| Schramek N et al. | Artemisinin biosynthesis in growing plants of Artemisia annua. A 13CO2 study. | 2010 | Phytochemistry | pmid:19932496 |
| Huang M et al. | Variation of herbivore-induced volatile terpenes among Arabidopsis ecotypes depends on allelic differences and subcellular targeting of two terpene synthases, TPS02 and TPS03. | 2010 | Plant Physiol. | pmid:20463089 |
| Jauhiainen M et al. | Analysis of endogenous ATP analogs and mevalonate pathway metabolites in cancer cell cultures using liquid chromatography-electrospray ionization mass spectrometry. | 2009 | J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. | pmid:19665949 |
| Anthony JR et al. | Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene. | 2009 | Metab. Eng. | pmid:18775787 |
| Rothwell C et al. | Cholesterol biosynthesis modulation regulates dengue viral replication. | 2009 | Virology | pmid:19419745 |
| Iriti M and Faoro F | Chemical diversity and defence metabolism: how plants cope with pathogens and ozone pollution. | 2009 | Int J Mol Sci | pmid:20111684 |
| Raemer PC et al. | Statins inhibit NK-cell cytotoxicity by interfering with LFA-1-mediated conjugate formation. | 2009 | Eur. J. Immunol. | pmid:19424968 |
| Suzuki M et al. | Complete blockage of the mevalonate pathway results in male gametophyte lethality. | 2009 | J. Exp. Bot. | pmid:19363204 |
| Balibar CJ et al. | The mevalonate pathway of Staphylococcus aureus. | 2009 | J. Bacteriol. | pmid:19028897 |
| Khan MA et al. | Statins impair CD1d-mediated antigen presentation through the inhibition of prenylation. | 2009 | J. Immunol. | pmid:19342651 |
| Alvarez Y et al. | Cyclooxygenase-2 induced by zymosan in human monocyte-derived dendritic cells shows high stability, and its expression is enhanced by atorvastatin. | 2009 | J. Pharmacol. Exp. Ther. | pmid:19318593 |
| Niessen J et al. | Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin. | 2009 | Drug Metab. Dispos. | pmid:19237515 |
| Dueber JE et al. | Synthetic protein scaffolds provide modular control over metabolic flux. | 2009 | Nat. Biotechnol. | pmid:19648908 |
| Wali VB et al. | Suppression in mevalonate synthesis mediates antitumor effects of combined statin and gamma-tocotrienol treatment. | 2009 | Lipids | pmid:19777282 |